KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 293 filers reported holding KARUNA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,005,747 | -34.5% | 5,948 | -16.0% | 0.02% | -32.1% |
| Q2 2023 | $1,535,732 | -92.9% | 7,082 | -96.3% | 0.03% | -85.6% |
| Q2 2021 | $21,763,000 | -12.5% | 190,923 | -7.7% | 0.19% | -16.0% |
| Q1 2021 | $24,871,000 | +7.0% | 206,864 | -9.6% | 0.23% | +6.9% |
| Q4 2020 | $23,251,000 | +29.8% | 228,867 | -1.2% | 0.22% | +9.6% |
| Q3 2020 | $17,912,000 | -30.6% | 231,656 | 0.0% | 0.20% | -37.5% |
| Q2 2020 | $25,820,000 | +57.7% | 231,656 | +1.9% | 0.32% | +14.1% |
| Q1 2020 | $16,368,000 | – | 227,338 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 782,008 | $142,043,933 | 58.49% |
| Nan Fung Group Holdings Ltd | 225,688 | $40,993,968 | 27.90% |
| Sofinnova Investments, Inc. | 1,773,124 | $322,070,243 | 20.60% |
| Artia Global Partners LP | 88,831 | $16,135,263 | 5.96% |
| DAFNA Capital Management LLC | 78,573 | $14,272,000 | 4.28% |
| First Light Asset Management, LLC | 243,675 | $44,261,127 | 3.98% |
| CATALYST PRIVATE WEALTH, LLC | 21,837 | $3,966,473 | 2.74% |
| Sands Capital Ventures, LLC | 58,895 | $10,697,688 | 2.64% |
| ARCH Venture Management, LLC | 30,000 | $5,449,200 | 2.63% |
| Logos Global Management LP | 100,000 | $18,164,000 | 2.60% |